DXP Enterprises, Inc. (NASDAQ:DXPE ) Q1 2025 Earnings Conference Call May 8, 2025 11:30 AM ET Company Participants Kent Yee – Chief Financial Officer David Little – Chairman and Chief Executive Officer Conference Call Participants Zach Marriott – Stephens Operator Ladies and gentlemen, thank you for standing by. My name is Krista and I will be your conference operator today.
The latest trading day saw DXP Enterprises (DXPE) settling at $88.98, representing a +0.59% change from its previous close.
The S&P 500 has notched seven days of consecutive gains as Donald Trump has signalled he will lower the 145% reciprocal tariff on China and ease pressure on the Federal. While U.S. equities rebound, corporate earnings could help clarify how tariffs have impacted corporate America thus far as more profitability data trickles in. While optimism on Wall Street should be tempered, a number of fundamentally strong stocks have exhibited a rebound over the past several weeks.
Cash is a company's lifeblood, a measure of resiliency and indicator of its true financial health. So, companies with rising cash flows like GFF, NOMD, DXPE and LMB are worth buying.
DXP Enterprises (DXPE) closed at $85.28 in the latest trading session, marking a +0.33% move from the prior day.
Here is how DXP Enterprises (DXPE) and Insteel Industries (IIIN) have performed compared to their sector so far this year.
We recommend investing in five old economy stocks with a favorable Zacks Rank for short-term double-digit upside potential. These are: PCG, FIX, DXPE, PGR, GE.
DXP Enterprises (DXPE) possesses solid growth attributes, which could help it handily outperform the market.
DXP Enterprises (DXPE) concluded the recent trading session at $80.32, signifying a +0.95% move from its prior day's close.
Cash gives a company vitality and strength and can indeed be referred to as its lifeblood. So, GFF, DXPE, WLDN and KINS, with rising cash flows, are worth buying.
DXP Enterprises (DXPE) possesses solid growth attributes, which could help it handily outperform the market.
Despite seeing a 50% increase in DXP's share price over the past year, I believe DXP is undervalued at current levels, with a P/S of 0.72 and strong fundamentals. Management is raising EBITDA targets to 11% for FY 2025. It seems that the recent M&As are not impacting margins. That said, I'm concerned about rising intangibles and a negative tangible book value, which pressures the quality of their balance sheet.